Berenberg Bank Lowers Dr. Martens (LON:DOCS) Price Target to GBX 110

Dr. Martens (LON:DOCS) had its target price lowered by stock analysts at Berenberg Bank from GBX 114 to GBX 110 in a research report issued to clients and investors on Tuesday,Digital Look reports. The brokerage currently has a “buy” rating on the stock. Berenberg Bank’s price target would suggest a potential upside of 65.17% from the stock’s previous close.

Separately, Royal Bank Of Canada reaffirmed a “sector perform” rating on shares of Dr. Martens in a report on Tuesday, February 3rd. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Dr. Martens has an average rating of “Moderate Buy” and a consensus price target of GBX 110.

Dr. Martens Price Performance

Shares of LON DOCS opened at GBX 66.60 on Tuesday. The stock has a market capitalization of £644.15 million, a PE ratio of 39.18, a P/E/G ratio of 6.40 and a beta of 0.22. The company has a debt-to-equity ratio of 120.66, a current ratio of 2.18 and a quick ratio of 1.13. The business has a fifty day moving average price of GBX 63.94 and a two-hundred day moving average price of GBX 71.49. Dr. Martens has a fifty-two week low of GBX 53.05 and a fifty-two week high of GBX 100.87.

Insider Activity

In other news, insider Ije Nwokori sold 204,051 shares of Dr. Martens stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of GBX 66, for a total value of £134,673.66. In the last 90 days, insiders acquired 930 shares of company stock valued at $59,984. Company insiders own 2.81% of the company’s stock.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.